BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38678042)

  • 1. Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.
    Cullen JK; Yap PY; Ferguson B; Bruce ZC; Koyama M; Handoko H; Hendrawan K; Simmons JL; Brooks KM; Johns J; Wilson ES; de Souza MMA; Broit N; Stewart P; Shelley D; McMahon T; Ogbourne SM; Nguyen TH; Lim YC; Pagani A; Appendino G; Gordon VA; Reddell PW; Boyle GM; Parsons PG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicines for an Enhanced Immunogenic Cell Death-Based
    Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H
    Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disulfiram derivative against lung cancer via the Notch signaling pathway without neurotoxicity and hepatotoxicity.
    Lv H; Yang H; Duan Y; Sha H; Zhao Z
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4747-4760. PubMed ID: 38147104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis-2'-F-cG
    Yu J; Yu X; Sun X; Wang Q; Long S; Ren R; Guan Z; Yang Z
    Mol Ther; 2024 Jun; 32(6):1917-1933. PubMed ID: 38637990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trehalose enhanced cold atmospheric plasma-mediated cancer treatment.
    Cao X; Fang T; Chen M; Ning T; Li J; Siegel PM; Park M; Chen Z; Chen G
    Biomaterials; 2024 Sep; 309():122582. PubMed ID: 38678699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized Sustained Release of Copper Enhances Antitumor Effects of Disulfiram in Head and Neck Cancer.
    Wang J; Li B; Cooper RC; Huang D; Yang H
    Biomacromolecules; 2024 May; 25(5):2770-2779. PubMed ID: 38687975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Refolding of Denatured IL-12 Using In Situ Antigen-Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy.
    Zhang Y; Ma F; Chen J; Chen Y; Xu L; Li A; Liu Y; Ma R; Shi L
    Adv Mater; 2024 May; 36(19):e2309927. PubMed ID: 38387609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiating Immunogenic Cell Death in Cold Tumor with Functional Living Materials of FeAu-Methylene Blue Composites.
    Wang T; Wang Y; Liu T; Yu F; Liu L; Xiong H; Xu W; Fan X; Liu X; Jiang H; Zhang H; Wang X
    Adv Healthc Mater; 2024 Jun; 13(14):e2302767. PubMed ID: 38381808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of tumor affects local and distant immune cell type and number.
    Hensel JA; Khattar V; Ashton R; Lee C; Siegal GP; Ponnazhagan S
    Immun Inflamm Dis; 2017 Mar; 5(1):85-94. PubMed ID: 28250928
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Qian Z; Zhang Z; Cen L; Ke Y; Shao J; Tian M; Liu B
    J Biomed Res; 2024 May; ():1-13. PubMed ID: 38807377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
    You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
    Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens.
    Lu Y; Pan Q; Gao W; Pu Y; Luo K; He B; Gu Z
    Biomaterials; 2022 Feb; 281():121335. PubMed ID: 34979419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
    Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
    Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
    Guo W; Jia L; Xie L; Kiang JG; Wang Y; Sun F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S; Wang X
    Cell Death Dis; 2024 Apr; 15(4):298. PubMed ID: 38678042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
    Wang X; Guo W; Jia L; Xie L; Kiang J; Wang Y; Wang F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S
    Res Sq; 2023 Aug; ():. PubMed ID: 37645899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.